Researchers also suggested that endocrine and metabolic changes beyond weight loss could contribute, although further investigation is required
Immunocompromised patients, premature infants, critically ill individuals, those with central venous catheters, and patients with severe acute pancreatitis should avoid GLP-1 probiotics due to elevated risk of serious infections and adverse outcomes
Importantly, while RCTs consistently demonstrate robust short-term glycemic improvements, real-world data suggest that long-term treatment continuity remains a major challenge
The hormonal drivers of appetite and weight gain that these medications address do not resolve simply because weight has been lost
GLP-1 medications are very concentrated, and only small amounts are needed per dose
Thats often when the question Whats wrong? starts to surface, but the answer isnt as clear-cut as you may think